Mylan Approved to Market CF Treatments, TOBI Solution and TOBI Podhaler, in UK - Cystic Fibrosis News Today
Mylan Approved to Market CF Treatments, TOBI Solution and TOBI Podhaler, in UK Cystic Fibrosis News Today
Mylan has been granted rights to market in the U.K. TOBI Solution and TOBI Podhaler to treat P. aeruginosa lung infections in cystic fibrosis patients.
Comments
Post a Comment